boAt delays stock market debut to reassess conditions and leadership shifts
Indian audio wearables brand boAt has delayed its second attempt to enter the stock market today to reassess market conditions. The company, which reported strong growth in Q1 FY26, is now focusing on internal readiness before proceeding. Meanwhile, cofounder Aman Gupta has stepped back from daily operations to launch a new venture.
boAt recorded an 11% rise in operating revenue for Q1 FY26, reaching ₹628.1 Cr compared to the same period last year. Total income for the quarter stood at ₹638.4 Cr, including ₹10.3 Cr from other sources. The company also maintained profitability, posting a net profit of ₹21.4 Cr in Q1 FY26 after a full-year profit of ₹60.4 Cr in FY25 on revenues of ₹3,073.3 Cr.
In September 2025, boAt appointed Gaurav Nayyar as CEO and Sameer Mehta as executive director for strategy. This leadership shift followed Aman Gupta's transition to a non-executive director role. Gupta has since launched OffBeat Studios, a separate business venture.
The company's planned stock market listing includes a fresh share issue of up to ₹500 Cr and an offer for sale of ₹1,000 Cr. Mehta and Gupta intend to sell shares worth ₹300 Cr, with the remaining stake sale by investors Fireside and Qualcomm. The delay comes amid a rapidly growing Indian market for audio wearables and smartwatches, where boAt competes with brands like Noise, Fire-Boltt, Apple, and Samsung.
boAt's decision to postpone its stock market listing reflects a focus on market timing and internal stability. The company remains profitable, with steady revenue growth in a competitive sector. Shareholders and investors will now await further updates on the stock market listing's revised timeline.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
